Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Singapore · Delayed Price · Currency is SGD

0.0290

+0.0020 (7.41%)

At close: Sep 11, 2026

Market Cap	50.00M +51.9%
Revenue (ttm)	15.72M +0.1%
Net Income	-23.90M
EPS	-0.02
Shares Out	1.72B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,990,300
Open	0.0280
Previous Close	0.0270
Day's Range	0.0280 - 0.0310
52-Week Range	0.0250 - 0.0890
Beta	0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima... [Read more]

Industry Medical Laboratories

Founded 2011

Country Singapore

Stock Exchange Singapore Exchange - Catalist

Ticker Symbol 9G2

Full Company Profile

Financial Performance

In fiscal year 2026, SGXC:9G2's revenue was 15.72 million, an increase of 0.05% compared to the previous year's 15.71 million. Losses were -23.90 million, -11.67% less than in 2025.

Financial Statements